Rare disease patient advocate Monica Weldon outlines some of the ethical conundrums around embryonic gene editing. With CRISPR technology again in the…

On 7 October 2020, the 2020 Nobel Prize in Chemistry was jointly awarded to Emmanuelle Charpentier and Jennifer A. Doudna "for the development of a…

David H. Crean, managing director for Objective Capital Partners, highlights the latest trends in the cell and gene therapy market for investments…

China is planning to establish a new national medical ethics committee in the wake of the “CRISPR babies” scandal. The committee will…

Jongmoon Kim, CEO of ToolGen discusses the potential for their CRISPR technology to revolutionize not only therapy for genetic illnesses, but also…